Home › Funds › Morgan Stanley › REPL

Morgan Stanley position in REPL

REPLIMUNE GROUP INC · Health Care

Latest position (Q2 2026)693.00K sh
Reported value held$7.67M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q3 2021 358.43K $10.62M New
Q4 2021 351.62K $9.53M Reduce
Q1 2022 586.85K $9.96M Add
Q2 2022 605.82K $10.59M Add
Q3 2022 558.43K $9.65M Reduce
Q4 2022 614.16K $16.71M Add
Q1 2023 849.45K $15.00M Add
Q2 2023 653.57K $15.18M Reduce
Q3 2023 469.36K $8.03M Reduce
Q4 2023 4.45M $37.49M Add
Q1 2024 2.65M $21.68M Reduce
Q2 2024 1.74M $15.62M Reduce
Q3 2024 1.69M $18.52M Reduce
Q4 2024 1.05M $12.69M Reduce
Q1 2025 928.26K $9.05M Reduce
Q1 2025 928.26K $9.05M Reduce
Q2 2025 921.66K $8.56M Reduce
Q2 2025 921.66K $8.56M Reduce
Q3 2025 1.38M $5.76M Add
Q4 2025 814.89K $7.92M Reduce
Q1 2026 646.21K $4.94M Reduce
Q2 2026 693.00K $7.67M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding REPL

All REPL fund holders →